(Q33992794)

30 July 2017

1 reference

title

Viral inactivation of fresh frozen plasma (English)

1 reference

30 July 2017

1 reference

Pamphilon D

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

British Journal of Haematology

30 July 2017

published in

1 reference

30 July 2017

volume

109

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

680-693

1 reference

Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Removal of methylene blue from plasma via an adsorbent filter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Target structures for HIV-1 inactivation by methylene blue and light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Storage and quality assessment of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

A universal virus inactivant for decontaminating blood and biopharmaceutical products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Virus reduction in the preparation of intravenous immune globulin: in vitro experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Acute hepatitis A in haemophiliacs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Inactivation of viruses during ultraviolet light treatment of human intravenous immunoglobulin and albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

SD Plasma in TTP and coagulation factor deficiencies for which no concentrates are available

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Current status of solvent/detergent-treated frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Outbreak of hepatitis A among Italian patients with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

No evidence for neoantigens in human plasma after photochemical virus inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Virus inactivation of blood products by phenothiazine dyes and light

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Acute hepatitis A in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Clinical studies with solvent detergent-treated products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Cost-effectiveness of transfusing virus-inactivated plasma instead of standard plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Effects of methylene blue-treated plasma on red cells and stored platelet concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

The use of tri(n-butyl)phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Leucocytes can be eliminated from plasma by filtration prior to viral inactivation with methylene blue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Clotting factors and hepatitis A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Why is fresh-frozen plasma transfused?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Augmented tumour necrosis factor in Reye's syndrome associated with dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Blood component treatment: a retrospective audit in five major London hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Factors affecting virus photoinactivation by a series of phenothiazine dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

Virally inactivated fresh frozen plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh-frozen plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02019.X

10.1046/J.1365-2141.2000.02019.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference